Cat. No. | Species | Product Description | Structure | Purity | Feature |
---|---|---|---|---|---|
IL8-H5113 | Human | Human IL-18 Protein, Tag Free (MALS verified) | ![]() |
![]() ![]() |
![]() ![]() |
Human IL-18BP, Fc Tag (Cat. No. ILP-H5253) captured on CM5 chip via Anti-human IgG Fc antibodies surface can bind Human IL-18, Tag Free (Cat. No. IL8-H5113) with an affinity constant of 1.71 nM as determined in a SPR assay (Biacore 8K) (Routinely tested).
Name | Research Code | Research Phase | Company | Indications | Clinical Trials |
---|---|---|---|---|---|
CMK-389 | CMK-389; NOV-8 | Novartis Pharma Ag | Details | ||
Tadekinig alfa (AB2 Bio) | Phase 3 Clinical | Ab2 Bio Ltd | Macrophage Activation Syndrome; Cytokine Release Syndrome; Lymphohistiocytosis, Hemophagocytic | Details | |
GSK-1070806 | GSK-1070806 | Phase 1 Clinical | Glaxosmithkline Plc | Rejection of renal transplantation; Inflammatory Bowel Diseases; Crohn Disease; Dermatitis, Atopic; Diabetes Mellitus | Details |
Camoteskimab | AVTX-007; MEDI-2338; AEVI-007; CERC-007 | Phase 1 Clinical | Medimmune Llc | Still's Disease, Adult-Onset; Multiple Myeloma; Pulmonary Disease, Chronic Obstructive | Details |
This web search service is supported by Google Inc.